REVIEW 1 cited by
Sources of Gain: Decomposing Performance in Conditional Average Dose Response Estimation
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
Signed reviews
read the original abstract
Estimating conditional average dose responses (CADR) is an important but challenging problem. Estimators must correctly model the potentially complex relationships between covariates, interventions, doses, and outcomes. In recent years, the machine learning community has shown great interest in developing tailored CADR estimators that target specific challenges. Their performance is typically evaluated against other methods on (semi-) synthetic benchmark datasets. Our paper analyses this practice and shows that using popular benchmark datasets without further analysis is insufficient to judge model performance. Established benchmarks entail multiple challenges, whose impacts must be disentangled. Therefore, we propose a novel decomposition scheme that allows the evaluation of the impact of five distinct components contributing to CADR estimator performance. We apply this scheme to eight popular CADR estimators on four widely-used benchmark datasets, running nearly 1,500 individual experiments. Our results reveal that most established benchmarks are challenging for reasons different from their creators' claims. Notably, confounding, the key challenge tackled by most estimators, is not an issue in any of the considered datasets. We discuss the major implications of our findings and present directions for future research.
Forward citations
Cited by 1 Pith paper
-
Uplift modeling with continuous treatments: A predict-then-optimize approach
A predict-then-optimize framework that estimates dose-response curves and allocates continuous treatments via integer linear programming, with fairness and cost-sensitive objectives.
Discussion (0). Continue with ORCID to comment.